BranchOut Food (BOF) vs Clene (CLNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
BranchOut Food (BOF) has outperformed Clene (CLNN) over the past year, gaining 64.8% versus a loss of 59.1%. BranchOut Food is the larger company by market cap ($56.3 million vs $54.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BOF | CLNN |
|---|---|---|
| Share price | $3.46 | $3.86 |
| Market cap | $56.26M | $54.87M |
| 1-day change | -2.26% | -0.52% |
| YTD return | +8.81% | -34.24% |
| 1-year return | +64.76% | -59.11% |
| 5-year return | — | -96.87% |
| EPS (TTM) | $-0.60 | $-3.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $13.50 |
| 52-week low | $2.00 | $3.25 |
| Distance from 52-week high | -34.10% | -71.41% |
| Analyst consensus | none | none |
| Avg. price target upside | +73.41% | +734.20% |
| Average volume | 27.27K | 100.43K |
| Shares outstanding | 16.26M | 14.21M |
| Employees | 314 | 76 |
| Sector | Consumer Staples | Health Care |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BOF has outperformed CLNN by 123.9 percentage points over the past year.
- The two companies sit in different sectors: BranchOut Food in Consumer Staples and Clene in Health Care.
About BranchOut Food
BOF stock →BranchOut Food Inc., together with its subsidiaries, develops, markets, sells, and distributes plant-based dehydrated fruit and vegetable snacks, and powders in the United States and Latin America. It offers pineapple chips, crunchy strawberry halves, strawberries, organic chewy banana slices, chewy banana slices, cinnamon churro, bell pepper crisps, carrot sticks under the BranchOut brand.
Consumer Staples · Packaged Foods · 314 employees
About Clene
CLNN stock →Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 76 employees
BOF vs CLNN FAQ
Which is bigger, BranchOut Food or Clene?
BranchOut Food (BOF) is larger, with a market capitalization of $56.26M compared with $54.87M for Clene (CLNN).
Which stock has performed better over the past year, BOF or CLNN?
BOF returned +64.76% over the past 12 months, compared with -59.11% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are BranchOut Food and Clene in the same industry?
No. BranchOut Food is in the Consumer Staples sector, while Clene is in Health Care.